AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

DOCS · NYSE · Medical - Healthcare Information Services

Doximity

Connects U.S. clinicians with marketing, hiring, and workflow tools.

$26.69

After-hours close−0.05 (−0.19%)

At close$26.74(+4.47%)

Something off on this page? Send us feedback.

Profile

Doximity, Inc.DOCSHealth Care

Runs a verified U.S. clinician network and sells Marketing, Hiring, and Workflow Solutions to pharmaceutical companies and health systems. Telehealth, news and research, career, scheduling, communications, and clinical-AI tools extend the platform.

Runs a virtual community for U.S. clinicians. Its tools support collaboration, patient-care coordination, virtual visits, current medical information, and career management, while bringing together telehealth, news and research, digital fax and e-signature, and Amion scheduling for clinician members.

Subscription-based Marketing, Hiring, and Workflow Solutions are sold principally to pharmaceutical companies and health systems. The Clinical AI Suite includes Ask, Scribe, and Dialer, while the Pathway acquisition added medical-AI clinical-reference capabilities.

Reliable handling of clinician and healthcare-related information, privacy and healthcare regulation, third-party systems, and continued clinician and enterprise-customer adoption shape the business.

Company facts

CEOJeffrey Tangney

ListedJun 24, 2021

ExchangeNYSE

HeadquartersSan Francisco, CA

CountryUnited States

Employees880

CIK0001516513

ISINUS26622P1075

Key statistics

Market cap$5.00B

EPS (ttm)$0.8500

P/E (ttm)31.45

ROE17.0%

P/B5.33

P/S7.63

Dividend yield—

Beta0.64vs XLV 0.06

Year to date −38.2% · Average volume (30d) 6.0M

Analysts

Price target, next 12 months$25.50−4.6%Median of 23 analysts · vs the Aug 28 close

ConsensusHold9 of 23 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $26.73

High$41.00+53.4%

Median$25.50−4.6%

Low$18.00−32.7%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Prior rating	Rating	Prior target	Target
Aug 13, 2026	Wolfe Research	Upgrade		Outperform
Aug 13, 2026	Truist Financial	Target			$19	$24
Aug 10, 2026	Wells Fargo	Downgrade	Overweight	Underweight
Aug 7, 2026	Needham	Reiterate		Buy	$27	$41
Aug 7, 2026	Evercore ISI	Target			$81	$40

Earnings

EPS

Estimate$0.34

ReportedDue Nov 5, 2026

Revenue

Estimate$170.6M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 6, 2026Q1 FY27	$0.30	$0.29	−4.3%	$151.8M	$156.6M	+3.2%	+32.62%
May 13, 2026Q4 FY26	$0.28	$0.26	−7.1%	$144.0M	$145.4M	+0.9%	−23.00%
Feb 5, 2026Q3 FY26	$0.44	$0.46	+4.5%	$181.6M	$185.1M	+1.9%	−16.78%
Nov 6, 2025Q2 FY26	$0.38	$0.45	+18.8%	$157.9M	$168.5M	+6.7%	−13.25%

View details

Financial highlights

	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	$138.3M	$145.9M	$168.5M	$185.1M	$145.4M	$156.6M
Gross profit	$123.8M	$130.1M	$152.1M	$166.4M	$126.0M	$132.9M
Operating income	$48.7M	$54.5M	$63.7M	$71.9M	$24.8M	$33.6M
Net income	$62.5M	$53.3M	$62.1M	$61.6M	$19.1M	$24.3M
Diluted EPS	$0.31	$0.27	$0.31	$0.31	$0.10	$0.13
Gross margin	89.5%	89.2%	90.3%	89.9%	86.7%	84.9%
Operating margin	35.2%	37.4%	37.8%	38.9%	17.1%	21.5%

Fiscal years (4-quarter sums)FY22 $343.5M · FY23 $419.1M · FY24 $475.4M · FY25 $570.4M · FY26 $644.9M

Revenue by product · Q1 FY27

Subscription$146.3M · 93%

Service, Other$10.3M · 7%

Balance sheet, Jun 30, 2026Cash & short-term investments $687.8M · Total debt $9.7M · Total assets $1.08B · Shareholders' equity $916.1M

Dividends

No dividends on record.

Ownership

Institutions 70.36%131.60M sharesInsiders 2.02%3.77M sharesOther 27.62%51.66M shares

Shares outstanding 187.03M · Float 181.35M · 97.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	14.31M	7.65%	13F	Aug 7, 2026
Vanguard Portfolio Management LLC	6.39M	3.42%	13F	Aug 13, 2026
Vanguard Capital Management LLC	5.98M	3.20%	13F	Aug 13, 2026
D. E. Shaw & Co., Inc.	5.92M	3.17%	13F	Aug 14, 2026
Two Sigma Investments, LP	4.65M	2.48%	13F	Aug 14, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Aug 25, 2026	Kira Scherer Wampler	director	−2,000	$24.95
Aug 13, 2026	Siddharth Sitaram	officer: Chief Accounting Officer	−1,770	$24.94
Aug 7, 2026	Timothy S. Cabral	director	−7,500	$39.11
Jul 15, 2026	Siddharth Sitaram	officer: Chief Accounting Officer	−1,732	$22.02
Jun 8, 2026	Siddharth Sitaram	officer: Interim PAO	−2,444	$20.41